Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linrodostat + Nivolumab in Advanced Melanoma
NCT03329846Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2017
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of linrodostat in melanoma, sponsored by Bristol Myers Squibb. Started Nov 2017; status: completed.
02
Drugs
linrodostat
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT03329846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329846.